Pranav Garimella
pranavgarimella.bsky.social
Pranav Garimella
@pranavgarimella.bsky.social
Nephrology I Epidemiology I Biomarkers I Uromodulin I ADPKD I PAD I Powerlifting. CHCF Fellow. All activities = personal opinions.
Reposted by Pranav Garimella
Awesome infographic on genetic testing in ADPKD by Neera Dahl, @pranavgarimella.bsky.social and Fouad Chebib www.kidneynews.org/view/journal...
July 28, 2025 at 7:30 PM
Reposted by Pranav Garimella
Thank you to @pranavgarimella.bsky.social and @kidneyfund.bsky.social for the interview!
September 4, 2025 at 6:41 PM
Reposted by Pranav Garimella
Associations of Urine Biomarkers During Ambulatory Acute Kidney Injury With Subsequent Recovery in Kidney Function: Findings From the SPRINT Study

bit.ly/AJKDAscher25

@pranavgarimella.bsky.social
May 2, 2025 at 4:07 PM
Reposted by Pranav Garimella
Dotunirab - URAT-1 inhibitor which prevents uric acid reabsorption = uricosuric

Nice commentary from @pranavgarimella.bsky.social & Amy Li in @kireports.bsky.social www.kireports.org/article/S246...

Drugs mostly only available in Japan Department

#NephSky #RheumSky
May 5, 2025 at 12:32 PM
Reposted by Pranav Garimella
🚨Should we consider a new approach to enhance prognostication in PKD?

See our editorial on CJASN ⭐️👇
@asnkidney.bsky.social
#endPKD @pranavgarimella.bsky.social @ucsdhealthsci.bsky.social

journals.lww.com/cjasn/Fullte...
A Combination Approach to Improving Prognostication in... : Clinical Journal of the American Society of Nephrology
An abstract is unavailable.
journals.lww.com
March 12, 2025 at 6:14 AM
Happening now, Drs @hswapnil.medsky.social and @jordybc.bsky.social discuss resistant hypertension during day 3 of the @kidneyfund.bsky.social #KidneyActionWeek

Fantastic discussion!
March 5, 2025 at 4:25 PM
Reposted by Pranav Garimella
Fascinating read on the ever frustrating topic of publication fees: this paper estimates that between 2019 and 2023 researchers and institutions paid a whopping USD $8.968 billion for their findings to be freely accessible and that costs tripled during that time 💰

arxiv.org/abs/2407.16551
Estimating global article processing charges paid to six publishers for open access between 2019 and 2023
This study presents estimates of the global expenditure on article processing charges (APCs) paid to six publishers for open access between 2019 and 2023. APCs are fees charged for publishing in some ...
arxiv.org
March 5, 2025 at 6:50 AM
Reposted by Pranav Garimella
@pranavgarimella.bsky.social, Chief Medical Officer of the American Kidney Fund, sat down with Dr. Vasishta Tatapudi of NYU Langone Health for a deep dive into xenotransplantation and what it means for the kidney community. Watch the full interview: bit.ly/4khsp23
Dr. Pranav Garimella, Chief Medical Officer of AKF & Dr. Vasishta Tatapudi | Xenotransplantation
Dr. Pranav Garimella, Chief Medical Officer of the American Kidney Fund, sits down with Dr. Vasishta Tatapudi, a transplant nephrologist at NYU Langone, for a deep dive into the FDA’s recent approval of xenotransplantation clinical trials and what it means for the kidney community.
bit.ly
February 28, 2025 at 5:25 PM
Reposted by Pranav Garimella
AKF Chief Medical Officer @pranavgarimella.bsky.social sat down with @pharmacytimes.bsky.social to discuss the recent FDA approval of semaglutide to reduce kidney disease & cardiovascular death risks in adults with type 2 diabetes & chronic kidney disease. Watch the interview: bit.ly/41sSynb
Expert: Approval of Semaglutide Major Advancement for CKD, Cardiovascular Risk Reduction in Type 2 Diabetes
Semaglutide has been approved for reducing kidney disease progression and cardiovascular risk in patients with type 2 diabetes, marking a significant advancement in CKD management.
www.pharmacytimes.com
February 21, 2025 at 4:11 PM
Reposted by Pranav Garimella
Hey #NephSky anyone ever heard of orthotopic kidney transplant (nephrectomy & transplant combined)? Have a patient with a good match living donor but poor femoral vessel targets due to calcium. Been turned down twice for kidney transplant surgery due to calcified vessels.
February 4, 2025 at 5:16 PM
Finally, the KDIGO 2025 #ADPKD Guidelines are out.
Whats in it?

✅ Genetic screening for persons at risk
✅ Best approach to managing cyst infection
✅ Considerations for treatment with tolvaptan
✅ ADPKD and mental health

All this and much more! www.kidney-international.org/article/S008...
January 21, 2025 at 3:28 PM
I am happy to announce my appointment as @kidneyfund.bsky.social first Chief Medical Officer! I look forward to lending my clinical expertise to help AKF better serve the 1 in 7 Americans living with kidney disease & joining an organization that fights kidney disease on all fronts.
AKF is excited to welcome @pranavgarimella.bsky.social as our Chief Medical Officer! As a leader in nephrology & expert in rare kidney diseases, Dr. Garimella will enhance our capacity to serve both the patient and clinical communities. Read more: bit.ly/4gOmn6W
January 8, 2025 at 4:56 PM
Hello Blue Sky
December 5, 2024 at 2:41 PM